Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Lilly Entitled to Longer Protection of Raloxifene;Netherlands Removes Partial Patent Validity Law;Sanctionable Conduct Does Not Always Justify Award of Attorney Fees;Invitrogen–GE Healthcare Suit Sent to Texas;CAFC Rejects Appeal in HPV Case;Ariad,MIT Patent on Transcription Factor Fails Written Description Test;Motion for Summary Judgment of Non-Infringement Denied